MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection, Expanding Non-Invasive Safety Screening
MindBio Therapeutics has created a language-agnostic AI speech model that detects drug and alcohol intoxication across multiple languages, enabling scalable, non-invasive testing for high-volume safety screening in industries like mining, aviation, and construction.
MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the development of a language-agnostic AI speech model capable of detecting drug and alcohol intoxication across multiple languages. This advancement represents a significant step toward scalable, non-invasive testing for industries that require high-volume safety screening, such as mining, aviation, construction, and law enforcement.
The AI prediction model utilizes over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The company is building an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication. These kiosks are designed for deployment in environments where safety is paramount, offering a quick, non-invasive alternative to traditional testing methods like breathalyzers or blood tests.
"This technology has the potential to revolutionize workplace safety by providing a fast, accurate, and non-intrusive way to screen for impairment," the company stated in the press release. The cross-language capability is particularly important for global operations, as it allows the system to be used in diverse linguistic environments without the need for separate models for each language.
The implications of this announcement are far-reaching. For industries like mining and aviation, where even momentary impairment can lead to catastrophic accidents, a reliable and instantaneous screening tool could save lives. Traditional testing methods are often time-consuming, require specialized equipment, and can be invasive. MindBio's voice-based AI system could be deployed at entry points, allowing employers to screen workers quickly before they begin their shifts. This could also reduce the stigma and privacy concerns associated with drug and alcohol testing.
Moreover, the scalability of the technology makes it suitable for high-volume settings, such as large construction sites or law enforcement checkpoints. The ability to detect not just alcohol but also drugs expands its utility, addressing a critical gap in current screening methods. As regulations around workplace safety tighten globally, companies may increasingly adopt such AI-driven solutions to comply with standards and mitigate liability.
MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for intoxication detection via voice analysis. The company is focused on bringing its enterprise platform to market, targeting industries where safety is non-negotiable. For more information, visit the company's newsroom at https://ibn.fm/MBQIF.